Company intelligence / Profile preview
Oxolife
Barcelona / Sant Quirze del Vallès, Catalonia, Spainoxolife.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Oxolife’s lead compound, OXO-001, is a non-hormonal oral pill designed to enhance endometrial receptivity and improve embryo implantation rates. It addresses an unmet medical need since no current treatments target the implantation phase directly. Phase II results demonstrated significant improvements in ongoing pregnancy rates (+10.6 percentage points) and live birth rates (+6.9 percentage points) compared to placebo among women undergoing IVF with donor eggs[4]. The drug also shows promise for treating PCOS-related infertility[3].
- Therapeutic areas
- Women's Health
- Modalities
- Non-hormonal oral drug treatment (small molecule-based)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Collaborations with University of CordobaRutgers University; partnerships planned with pharmaceutical companies post-clinical trials[3][5]
Beyond the preview
Go deeper on Oxolife.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Oxolife.